{"result":[{"lastName":"Kurian","clinicalFocus":[{"focus":"Cancer Genetics"},{"focus":"Medical Oncology"},{"focus":"Breast Cancer Risk"}],"appointments":[{"appointment":"Assistant Professor - Med Center Line,Medicine - Oncology"},{"appointment":"Member,Stanford Cancer Institute"},{"appointment":"Assistant Professor - Med Center Line,Health Research & Policy"}],"primaryAppointment":"Assistant Professor - Med Center Line,Medicine - Oncology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=6431&type=small&showNoImage","displayName":"Allison W. Kurian, M.D., M.Sc.","firstName":"Allison","href":"http://med.stanford.edu/profiles/cancer/researcher/Allison_Kurian","researchInterest":"Breast and gynecologic cancer genetics, epidemiology, prevention, and outcomes."},{"lastName":"Sikic","clinicalFocus":[{"focus":"Medical Oncology"},{"focus":"New Drug Studies"}],"appointments":[{"appointment":"Professor,Medicine - Oncology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor,Medicine - Oncology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4131&type=small&showNoImage","displayName":"Branimir I. Sikic, M. D.","firstName":"Branimir","href":"http://med.stanford.edu/profiles/cancer/researcher/Branimir_Sikic","researchInterest":"Research Interests: cancer pharmacology, mechanisms of resistance to anticancer drugs, regulation and function of MDR1 and tubulin genes, clinical trials of modulation of drug resistance, general oncology, Phase I trials of new drugs, gene expression profiling of cancers"},{"lastName":"Chang","clinicalFocus":[{"focus":"Radiation Oncology"},{"focus":"Cancer of the Stomach"},{"focus":"Cancer of Anus"},{"focus":"Cancer of Pancreas"},{"focus":"Cancer of the Rectum"},{"focus":"Cancer of the Liver"},{"focus":"Cancer of the Esophagus"},{"focus":"Cancer of the Head and Neck"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Radiation Oncology - Radiation Therapy"},{"appointment":"Member,Bio-X"}],"primaryAppointment":"Associate Professor - Med Center Line,Radiation Oncology - Radiation Therapy","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=8238&type=small&showNoImage","displayName":"Daniel Chang","firstName":"Daniel","href":"http://med.stanford.edu/profiles/cancer/researcher/Daniel_Chang","researchInterest":"I specialize in the treatment of gastrointestinal malignancies.  I am interested in developing stereotactic body radiotherapy for tumors of the liver, both primary and metastatic.  I am interested in developing functional imaging as a means of determining treatment response with radiation.  I am also interested in developing image-guided radiotherapy to improve radiation delivery for GI cancers to reduce toxicity and improve disease outcome."},{"lastName":"Jensen","clinicalFocus":[{"focus":"Pathology"},{"focus":"Cytopathology"},{"focus":"Anatomic Pathology"}],"appointments":[{"appointment":"Assistant Professor - Med Center Line,Pathology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Assistant Professor - Med Center Line,Pathology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=7660&type=small&showNoImage","displayName":"Kristin Jensen","firstName":"Kristin","href":"http://med.stanford.edu/profiles/cancer/researcher/Kristin_Jensen","researchInterest":"I am a clinical translational investigator with a primary interest in breast cancer biology, and the use of investigational and clinical ancillary techniques such as gene and tissue microarray analysis and immunohistochemistry in the diagnosis and prognosis of this disease. As a practicing cytopathologist, I also have an interest in improving the fine needle aspiration biopsy diagnosis of breast lesions, again using immunohistochemistry and gene expression analysis as adjuncts to cytomorphology."},{"lastName":"Alli","clinicalFocus":[],"appointments":[{"appointment":"Instructor,Medicine - Oncology"}],"primaryAppointment":"Instructor,Medicine - Oncology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=9711&type=small&showNoImage","displayName":"Elizabeth Alli","firstName":"Elizabeth","href":"http://med.stanford.edu/profiles/cancer/researcher/Elizabeth_Alli","researchInterest":"I am interested in identifying targeted therapies for triple-negative breast cancers and developing a novel strategy of biomarker-based chemoprevention for hereditary cancers that arise due to mutations in the Breast Cancer Susceptibility Gene 1 (BRCA1)."},{"lastName":"Giaccia","clinicalFocus":[],"appointments":[{"appointment":"Professor,Radiation Oncology - Radiation and Cancer Biology"},{"appointment":"Member,Stanford Cancer Institute"},{"appointment":"Professor (By courtesy),Obstetrics & Gynecology"},{"appointment":"Professor (By courtesy),Surgery"}],"primaryAppointment":"Professor,Radiation Oncology - Radiation and Cancer Biology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4141&type=small&showNoImage","displayName":"Amato J. Giaccia","firstName":"Amato","href":"http://med.stanford.edu/profiles/cancer/researcher/Amato_Giaccia","researchInterest":"During the last five years, we have identified several small molecules that kill VHL deficient renal cancer cells through a synthetic lethal screening approach. Another major interest of my laboratory is in identifying hypoxia-induced genes involved in invasion and metastases. We are also investigating how hypoxia regulates gene expression epigenetically."},{"lastName":"Whittemore","clinicalFocus":[],"appointments":[{"appointment":"Professor,Health Research & Policy - Epidemiology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor,Health Research & Policy - Epidemiology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4482&type=small&showNoImage","displayName":"Alice S Whittemore","firstName":"Alice","href":"http://med.stanford.edu/profiles/cancer/researcher/Alice_Whittemore","researchInterest":"Cancers of the prostate, breast and ovary account for a major proportion of new cancer cases and cancer deaths in the U.S. each year. Our recent research focus has been on developing improved statistical methods for the design and conduct of studies involving hereditary predisposition and modifiable lifestyle characteristics in the etiologies of site-specific cancers."},{"lastName":"Hanawalt","clinicalFocus":[],"appointments":[{"appointment":"Professor,Biology (School of Humanities and Sciences)"},{"appointment":"Member,Bio-X"},{"appointment":"Member,Stanford Cancer Institute"},{"appointment":"Professor,Dermatology"}],"primaryAppointment":"Professor,Biology (School of Humanities and Sciences)","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=5957&type=small&showNoImage","displayName":"Philip C. Hanawalt","firstName":"Philip","href":"http://med.stanford.edu/profiles/cancer/researcher/Philip_Hanawalt","researchInterest":"Our current research focuses in two principal areas:\r\n\r\n1. The molecular basis for  diseases in which the pathway of transcription-coupled DNA repair is defective, including Cockyne syndrome (CS) and UV-sensitive syndrome (UVSS). Patients are severely sensitive to sunlight  but  get no cancers. See Hanawalt & Spivak, 2008, for review.\r\n\r\n2. Transcription arrest by guanine-rich DNA sequences and non-canonical secondary structures. Transcription collisions with replication forks."},{"lastName":"John","clinicalFocus":[],"appointments":[{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Member,Stanford Cancer Institute","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=7425&type=small&showNoImage","displayName":"Esther M. John","firstName":"Esther","href":"http://med.stanford.edu/profiles/cancer/researcher/Esther_John","researchInterest":"Etiology of breast, prostate and ovarian cancer; cancer in Hispanics and African-Americans; migration and acculturation in Hispanics; modifiable lifestyle factors (vitamin D, physical activity, body size, heterocyclic amines, occupational exposures); genetic susceptibility; gene-environment interactions"},{"lastName":"Chu","clinicalFocus":[{"focus":"Oncology"}],"appointments":[{"appointment":"Professor,Medicine - Oncology"},{"appointment":"Member,Bio-X"},{"appointment":"Member,Stanford Cancer Institute"},{"appointment":"Professor,Biochemistry"}],"primaryAppointment":"Professor,Medicine - Oncology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4149&type=small&showNoImage","displayName":"Gilbert Chu","firstName":"Gilbert","href":"http://med.stanford.edu/profiles/cancer/researcher/Gilbert_Chu","researchInterest":"Our laboratory focuses on understanding how cells respond to DNA damage. Our research currently involves areas that interact with each other: repair of radiation damage, and transcriptional responses to DNA damage."},{"lastName":"Cho-Phan","clinicalFocus":[{"focus":"Gastrointestinal Cancers"},{"focus":"Medical Oncology"},{"focus":"Oncology (Cancer)"}],"appointments":[{"appointment":"Clinical Assistant Professor,Medicine - Oncology"}],"primaryAppointment":"Clinical Assistant Professor,Medicine - Oncology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=3864&type=small&showNoImage","displayName":"Cheryl Cho-Phan","firstName":"Cheryl","href":"http://med.stanford.edu/profiles/cancer/researcher/Cheryl_Cho-Phan","researchInterest":""},{"lastName":"Brown","clinicalFocus":[],"appointments":[{"appointment":"Professor Emeritus,Radiation Oncology - Radiation and Cancer Biology"},{"appointment":"Emeritus Faculty, Acad Council,Radiation Oncology - Radiation and Cancer Biology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor Emeritus,Radiation Oncology - Radiation and Cancer Biology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4536&type=small&showNoImage","displayName":"Martin Brown","firstName":"Martin","href":"http://med.stanford.edu/profiles/cancer/researcher/Martin_Brown","researchInterest":"We seek to understand the mechanisms responsible for the resistance of cancers to treatment and to develop strategies to overcome these resistances. We are using molecular and cellular techniques and mouse models to potentiate the activity of radiation on tumors by inhibiting the bone marrow rescue of the tumor vasculature following therapy."},{"lastName":"Villalobos","clinicalFocus":[],"appointments":[{"appointment":"Postdoctoral Medical fellow, Medicine"}],"primaryAppointment":"Postdoctoral Medical fellow, Medicine","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=23326&type=small&showNoImage","displayName":"Victor Villalobos MD, PhD","firstName":"Victor","href":"http://med.stanford.edu/profiles/postdocs/researcher/Victor_Villalobos","researchInterest":""},{"lastName":"Shelton","clinicalFocus":[{"focus":"Rectal Cancer "},{"focus":"Colon and Rectal Surgery"},{"focus":"Colorectal Cancer"},{"focus":"Crohn's Disease"},{"focus":"Colorectal Cancer - Surgery"},{"focus":"Gastrointestinal Cancers"},{"focus":"Gastrointestinal Cancers - Surgical Oncology"},{"focus":"General Surgery"},{"focus":"Inflammatory Bowel Diseases"},{"focus":"Ulcerative Colitis"},{"focus":"Laparoscopic colorectal surgery"},{"focus":"Minimally Invasive Surgical Procedures"}],"appointments":[{"appointment":"Clinical Associate Professor,Surgery - General Surgery"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Clinical Associate Professor,Surgery - General Surgery","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=3886&type=small&showNoImage","displayName":"Andrew A. Shelton, M.D.","firstName":"Andrew","href":"http://med.stanford.edu/profiles/cancer/researcher/Andrew_Shelton","researchInterest":"Multimodality treatment of rectal cancer\r\nSphincter preserving procedures for rectal cancer\r\nLaparoscopic colon and rectal surgery\r\nSurgical education"},{"lastName":"Welton","clinicalFocus":[{"focus":"Anal Cancer "},{"focus":"Basal / Squamous Cell Carcinomas"},{"focus":"Basal / Squamous Cell Carcinomas - Surgery"},{"focus":"Carcinoid Tumors"},{"focus":"Carcinoid Tumors - Surgery "},{"focus":"Colon and Rectal Surgery"},{"focus":"Colorectal Cancer"},{"focus":"Colorectal Cancer - Surgery"},{"focus":"Gastrointestinal Cancers"},{"focus":"Gastrointestinal Cancers - Surgical Oncology"},{"focus":"Inflammatory Bowel Disease"},{"focus":"Rectal Cancer "},{"focus":"Rectal Cancer - Surgery"}],"appointments":[{"appointment":"Professor - Med Center Line,Surgery - General Surgery"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor - Med Center Line,Surgery - General Surgery","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=3835&type=small&showNoImage","displayName":"Mark Lane Welton","firstName":"Mark","href":"http://med.stanford.edu/profiles/cancer/researcher/Mark_Welton","researchInterest":"Clinical research focused on the diagnosis, prevention and treatment of anal cancer and its precursor lesions.  Clinical trials of ablative therapy for High-grade Squamous Intraepithelial Lesions (HSIL) of the anus and perianal tissues as a means for preventing anal cancer.\r\nBasic science work in collaboration with Ronald Davis and Hanlee Ji focused on the molecular genetic and pathologic studies of anal cancers using moecular inversion probe genomic technology"},{"lastName":"Goodman","clinicalFocus":[],"appointments":[{"appointment":"Professor,Medicine - General Medical Disciplines"},{"appointment":"Professor,Health Research & Policy - Epidemiology"}],"primaryAppointment":"Professor,Medicine - General Medical Disciplines","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=23410&type=small&showNoImage","displayName":"Steven Goodman","firstName":"Steven","href":"http://med.stanford.edu/profiles/cancer/researcher/Steven_Goodman","researchInterest":"I am interested in issues relating to the representation and measurement of evidence in medical research, and determinants of the truth of medical findings, using a Bayesian framework. I also do work in evidence synthesis, comparative effectiveness research, and the ethics of clinical research. Finally, I have an ongoing project related to landmark clinical trials that have had great impact."},{"lastName":"King","clinicalFocus":[],"appointments":[{"appointment":"Instructor,Pediatrics - Neonatal and Developmental Medicine"}],"primaryAppointment":"Instructor,Pediatrics - Neonatal and Developmental Medicine","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=10623&type=small&showNoImage","displayName":"Bonnie King, PhD","firstName":"Bonnie","href":"http://med.stanford.edu/profiles/cancer/researcher/Bonnie_King","researchInterest":"My areas of interest are mammary gland biology and translational breast cancer research. I recently joined the Contag lab as an NIH Career Re-Entry Scientist, where I am using molecular imaging tools to study the process of cancer cell dissemination during breast cancer progression."},{"lastName":"Chung","clinicalFocus":[],"appointments":[{"appointment":"Basic Life Science Research Associate,Obstetrics & Gynecology"}],"primaryAppointment":"Basic Life Science Research Associate,Obstetrics & Gynecology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=10387&type=small&showNoImage","displayName":"Young Min Chung","firstName":"Young Min","href":"http://cancer.stanford.edu/profiles/Young Min_Chung","researchInterest":""},{"lastName":"Jeffrey","clinicalFocus":[{"focus":"General Surgery"}],"appointments":[{"appointment":"Professor - Med Center Line,Surgery - General Surgery"},{"appointment":"Member,Bio-X"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor - Med Center Line,Surgery - General Surgery","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4147&type=small&showNoImage","displayName":"Stefanie S. Jeffrey, MD","firstName":"Stefanie","href":"http://med.stanford.edu/profiles/cancer/researcher/Stefanie_Jeffrey","researchInterest":"Dr. Jeffrey was team leader of the multidisciplinary team from the School of Medicine, School of Engineering, and Genome Technology Center that invented the MagSweeper automated technology to isolate live circulating tumor cells (CTCs) from cancer patient blood for single cell analysis. Her lab characterizes CTCs in different cancers, investigating CTC profiles and mutations as potential companion diagnostics to define individual patient response to newer biologically-based cancer therapies."},{"lastName":"Balise","clinicalFocus":[],"appointments":[{"appointment":"Sr Research Engineer,Health Research & Policy - Epidemiology"}],"primaryAppointment":"Sr Research Engineer,Health Research & Policy - Epidemiology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=25948&type=small&showNoImage","displayName":"Raymond Balise","firstName":"Raymond","href":"http://cancer.stanford.edu/profiles/Raymond_Balise","researchInterest":""},{"lastName":"Clarke","clinicalFocus":[],"appointments":[{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Member,Stanford Cancer Institute","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=7430&type=small&showNoImage","displayName":"Christina Clarke","firstName":"Christina","href":"http://med.stanford.edu/profiles/cancer/researcher/Christina_Clarke","researchInterest":"Dr. Clarke\u0092s research efforts are centered in five areas: 1) the epidemiology of breast cancer, 2) the epidemiology of lymphoid malignancies 3) immunologic and viral causes of malignancy, and 4) cancer surveillance and creative uses of and ways to visually display cancer surveillance data (e.g, SEER, cancer registry data) and more recently, 5) internet-based, patient-centric methods for recruitment and data collection in epidemiologic studies."},{"lastName":"West","clinicalFocus":[],"appointments":[{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Member,Stanford Cancer Institute","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=6327&type=small&showNoImage","displayName":"Dee W. West","firstName":"Dee","href":"http://med.stanford.edu/profiles/cancer/researcher/Dee_West","researchInterest":"- Cancer etiology (diet, familial, genetic), especially breast, prostate and colon cancer\r\n- Cancer surveillance (Cancer registration, cancer patterns)\r\n- Cancer outcomes (Survival, quality of life, quality of care)"},{"lastName":"Pegram","clinicalFocus":[{"focus":"Oncology"}],"appointments":[{"appointment":"Professor - Med Center Line,Medicine - Oncology"},{"appointment":"Member,Bio-X"}],"primaryAppointment":"Professor - Med Center Line,Medicine - Oncology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=32170&type=small&showNoImage","displayName":"Mark Pegram","firstName":"Mark","href":"http://med.stanford.edu/profiles/cancer/researcher/Mark_Pegram","researchInterest":""},{"lastName":"Wapnir","clinicalFocus":[{"focus":"Breast Cancer"},{"focus":"Breast Cancer - Surgery"},{"focus":"Breast Surgery"},{"focus":"General Surgery"},{"focus":"Nipple-sparing mastectomy, breast conserving surgery, sentinel node biopsy"}],"appointments":[{"appointment":"Professor - Med Center Line,Surgery - General Surgery"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor - Med Center Line,Surgery - General Surgery","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4337&type=small&showNoImage","displayName":"Irene Wapnir","firstName":"Irene","href":"http://med.stanford.edu/profiles/cancer/researcher/Irene_Wapnir","researchInterest":"Clinical trials in operative procedures such as Nipple-sparing mastectomy, arm lymphatic mapping, skin perfusion and Treatments for Breast Cancer, especially local recurrence. Dr. Wapnir is institutional Principal Investigator and Chair for National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials. Laboratory and translational research includes exploring the activity of breast iodide transporter in breast cancer brain metastasis."},{"lastName":"van de Rijn","clinicalFocus":[{"focus":"Anatomic Pathology"},{"focus":"Sarcoma"}],"appointments":[{"appointment":"Professor - Med Center Line,Pathology"},{"appointment":"Member,Bio-X"},{"appointment":"Member,Child Health Research Institute"}],"primaryAppointment":"Professor - Med Center Line,Pathology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4008&type=small&showNoImage","displayName":"Matt van de Rijn","firstName":"Matt","href":"http://med.stanford.edu/profiles/cancer/researcher/Matt_van de Rijn","researchInterest":"Our research focuses on gene microarray analysis of human soft tissue tumors (sarcomas). In addition we work with tissue microarrays to characterize large numbers of novel antisera raised against peptides derived from genes found to be of interest during gene array analysis."}]}